Selective PI3Kδ Inhibitors as Anti-NASH Agents

被引：0
|
作者：
Vakkalanka, Swaroop
Muthuppalaniappan, Meyyappan
Babu, G.
Varanasi, Kanthikiran
Routhu, Kasiviswanath
Nyayapathy, Seeta
Veeraraghavan, Sridhar
Viswanadha, Srikant
Nagaratham, Dhanapalan
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
321-OR
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [31] Selective PI3K and dual PI3K/mTOR inhibitors enhance the efficacy of endocrine therapies in breast cancer models
    Friedman, L.
    Ross, L. B.
    Wallin, J.
    Guan, J.
    Prior, W. W.
    Wu, E.
    Nannini, M.
    Sampath, D.
    CANCER RESEARCH, 2012, 72
  • [32] PI3K and mTOR inhibitors - a new generation of targeted anticancer agents
    Brachmann, Saskia
    Fritsch, Christine
    Maira, Saveur-Michel
    Garcia-Echeverria, Carlos
    CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) : 194 - 198
  • [33] EFFECTS OF COMBINED EXPOSURE TO BRAF AND PI3K INHIBITORS WITH CHEMOTHERAPEUTIC AGENTS
    Egyhazi, S.
    Azimi, A.
    Ghasghgaei, S.
    Stolt, M. Frostvik
    Johansson, C. Hertzman
    Hansson, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 23
  • [34] PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma
    Sapon-Cousineau, Vladimir
    Sapon-Cousineau, Sasha
    Assouline, Sarit
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (06)
  • [35] PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma
    Vladimir Sapon-Cousineau
    Sasha Sapon-Cousineau
    Sarit Assouline
    Current Treatment Options in Oncology, 2020, 21
  • [36] Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
    Garrett, Joan T.
    Chakrabarty, Anindita
    Arteaga, Carlos L.
    ONCOTARGET, 2011, 2 (12) : 1314 - 1321
  • [37] Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels
    Dan, Shingo
    Sugita, Hironobu
    Yamazaki, Kanami
    Yamori, Takao
    CANCER RESEARCH, 2009, 69
  • [38] Pharmacokinetics of selective PI3Kδ inhibitors after intratracheal instillation in mice
    Gunerka, Pawel
    Hucz-Kalitowska, Joanna
    Turowski, Pawel
    Zagozda, Marcin
    Dziachan, Maciej
    Sekular, Mariola
    Bujak, Anna
    Wieczorek, Maciej
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] Preclinical profile of novel, potent, and selective PI3K delta inhibitors
    Vakkalanka, Swaroop
    Muthuppalaniappan, Meyyappan
    Babu, G.
    Varanasi, Kanthikiran V. S.
    Veeraraghavan, Sridhar
    Viswanadha, Srikant
    CANCER RESEARCH, 2011, 71
  • [40] Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
    Zhou, Hua
    McGowan, Meredeth A.
    Lipford, Kathryn
    Christopher, Matthew
    Fradera, Xavier
    Witter, David
    Lesburg, Charles A.
    Li, Chaomin
    Methot, Joey L.
    Lampe, John
    Achab, Abdelghani
    Shaffer, Lynsey
    Goldenblatt, Peter
    Shah, Sanjiv
    Bass, Alan
    Schroeder, Gottfried
    Chen, Dapeng
    Zeng, Haoyu
    Augustin, Martin A.
    Katz, Jason D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (01)
12345